2023
10 citations Research paper

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression

Weronika Dębowska, Magdalena Więdłocha, Marta Dębowska, Zuzanna Kownacka, Piotr Marcinowicz, Agata Szulc

Summary & key facts

This paper reviews research on using transcranial magnetic stimulation (TMS) together with ketamine to treat people whose depression does not improve with usual treatments. Both TMS and ketamine can lower depressive symptoms on their own. Some recent studies suggest that giving them together might create bigger or longer-lasting improvements. The review summarizes the existing studies, discusses possible brain mechanisms for combined effects, and highlights that more research is needed to work out the best ways to combine these treatments.

Key facts:
  • The review focuses on treatment-resistant depression, which means depressive illness that does not respond to standard treatments.
  • Both transcranial magnetic stimulation (TMS) and ketamine have been shown in studies to reduce the severity of depressive symptoms when used separately.
  • Some recent studies report that combining TMS with ketamine can produce stronger and possibly longer-lasting reductions in depressive symptoms compared with each treatment alone.
  • The paper is a review article: it summarizes and interprets existing studies rather than reporting a new clinical trial.
  • The authors state that evidence is still emerging and that optimal combined treatment protocols (timing, dosing, stimulation parameters) are not yet established.

Abstract

Drug-resistant mental disorders, particularly treatment-resistant depression, pose a significant medical and social problem. To address this challenge, modern psychiatry is constantly exploring the use of novel treatment methods, including biological treatments, such as transcranial magnetic stimulation (TMS), and novel rapid-acting antidepressants, such as ketamine. While both TMS and ketamine demonstrate high effectiveness in reducing the severity of depressive symptoms, some patients still do not achieve the desired improvement. Recent literature suggests that combining these two methods may yield even stronger and longer-lasting results. This review aims to consolidate knowledge in this area and elucidate the potential mechanisms of action underlying the increased efficacy of combined treatment, which would provide a foundation for the development and optimization of future treatment protocols.

Topics

Functional Brain Connectivity Studies Transcranial Magnetic Stimulation Studies Treatment of Major Depression

Categories

Life Sciences Neurology Neuroscience

Tags

Cognition Depression (economics) Economics Ketamine Macroeconomics Major depressive disorder Medicine Neuroscience Psychiatry Psychology Stimulation Transcranial magnetic stimulation Treatment-resistant depression

Substances

Ketamine

Conditions & symptoms

Depression Sadness or low mood
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.

Referencing articles

The Promise of Ketamine Therapy: A Hope for Treatment-Resistant Depression
Psychedelic Therapy
The Promise of Ketamine Therapy: A Hope for Treatment-Resistant Depression

Ketamine therapy offers rapid relief for treatment-resistant depression, with effects in hours instead of weeks.

Expert-Reviewed by: Dr. Anna Steinzeig